Class II · Moderate risk
Levothroid
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Thyroid Medication Recalls
Recalls of levothyroxine and other thyroid hormone replacement drugs, often over sub-potency.
235 recalls in this category, newest first.
Class II · Moderate risk
Levothroid
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class II · Moderate risk
Levothroid
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class II · Moderate risk
Levothroid
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class II · Moderate risk
Levothroid
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class II · Moderate risk
Levothroid
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened..
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened..
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened.
Class II · Moderate risk
Levoxyl (levothyroxine sodium)
Chemical contamination: emission of strong odor after package was opened..
Class III · Low risk
Liothyronine Sodium Tablets
Failed Impurities/Degradation Specifications: 3 month stability testing.
Class II · Moderate risk
Synthroid (Levothyroxine Sodium)
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Class II · Moderate risk
Levothyroxine Tablets
Subpotent; 15 month stability (by mfr)
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent; 15 month stability
Class II · Moderate risk
Levothroid
Subpotent; 9-month stability interval
Class II · Moderate risk
Levothroid
Subpotent; 9-month stability interval
Class II · Moderate risk
Synthroid (levothyroxine sodium)
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Class II · Moderate risk
Synthroid (levothyroxine sodium)
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.